.

Deeper Knowledge, Faster

  • Anticipate your formulary budget
  • Uncover prior art in expired and abandoned patents
  • Drug patents and clinical trials in dozens of countries

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Johnson and Johnson
Julphar
QuintilesIMS
Dow
Chubb
Cerilliant
US Department of Justice
Express Scripts
Moodys

Generated: June 23, 2017

DrugPatentWatch Database Preview

Details for Patent: 9,283,197

« Back to Dashboard

Which drugs does patent 9,283,197 protect, and when does it expire?


Patent 9,283,197 protects EPINEPHRINE and is included in one NDA.

Summary for Patent: 9,283,197

Title:More potent and less toxic formulations of epinephrine and methods of medical use
Abstract: The present invention provides pharmaceutical formulations of levorotatory-epinephrine, l-epinephrine, more potent and less toxic than existing pharmaceutical formulations of epinephrine, along with methods of producing and using these pharmaceutical formulations of l-epinephrine.
Inventor(s): Taneja; Jugal K. (Tampa, FL)
Assignee:
Application Number:14/460,845
Patent Claim Types:
see list of patent claims
Formulation; Compound;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Belcher Pharms Llc
EPINEPHRINE
epinephrine
SOLUTION;IV (INFUSION), INTRAOCULAR, INTRAMUSCULAR, SUBCUTANEOUS205029-001Jul 29, 2014RXNoNo9,283,197► SubscribeY INDUCTION AND MAINTENANCE OF MYDRIASIS DURING INTRAOCULAR SURGERY
Belcher Pharms Llc
EPINEPHRINE
epinephrine
SOLUTION;IV (INFUSION), INTRAOCULAR, INTRAMUSCULAR, SUBCUTANEOUS205029-001Jul 29, 2014RXNoNo9,283,197► SubscribeY EMERGENCY TREATMENT OF ALLERGIC REACTIONS (TYPE I), INCLUDING ANAPHYLAXIS
Belcher Pharms Llc
EPINEPHRINE
epinephrine
SOLUTION;IV (INFUSION), INTRAOCULAR, INTRAMUSCULAR, SUBCUTANEOUS205029-001Jul 29, 2014RXNoNo9,283,197► SubscribeY INCREASING MEAN ARTERIAL BLOOD PRESSURE IN ADULT PATIENTS WITH HYPOTENSION ASSOCIATED WITH SEPTIC SHOCK
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
Boehringer Ingelheim
Teva
Argus Health
Farmers Insurance
Medtronic
Express Scripts
Citi
QuintilesIMS
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot